2020 Q2 Form 10-Q Financial Statement
#000156459020039505 Filed on August 12, 2020
Income Statement
| Concept | 2020 Q2 | 2019 Q2 |
|---|---|---|
| Revenue | $15.00M | $0.00 |
| YoY Change | -100.0% | |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | -$1.080M | $2.800M |
| YoY Change | -138.57% | -10.83% |
| % of Gross Profit | ||
| Research & Development | $3.549M | $2.264M |
| YoY Change | 56.72% | -46.46% |
| % of Gross Profit | ||
| Depreciation & Amortization | $30.17K | $20.00K |
| YoY Change | 50.85% | 100.0% |
| % of Gross Profit | ||
| Operating Expenses | $3.549M | $5.979M |
| YoY Change | -40.65% | -18.87% |
| Operating Profit | -$5.979M | |
| YoY Change | -0.95% | |
| Interest Expense | -$430.0K | $290.4K |
| YoY Change | -248.08% | 524.95% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $295.3K | |
| YoY Change | 535.55% | |
| Pretax Income | -$4.690M | -$5.680M |
| YoY Change | -17.43% | -5.18% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$5.282M | -$5.684M |
| YoY Change | -7.07% | -5.11% |
| Net Earnings / Revenue | -35.21% | |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$1.94 | -$2.10 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 40.59M | |
| Diluted Shares Outstanding | 40.91M |
Balance Sheet
| Concept | 2020 Q2 | 2019 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $44.86M | $48.20M |
| YoY Change | -6.92% | -29.94% |
| Cash & Equivalents | $44.86M | $48.16M |
| Short-Term Investments | ||
| Other Short-Term Assets | $570.5K | $264.3K |
| YoY Change | 115.84% | 23.82% |
| Inventory | ||
| Prepaid Expenses | $368.0K | |
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $45.43M | $48.79M |
| YoY Change | -6.88% | -29.72% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $260.9K | $297.6K |
| YoY Change | -12.33% | 223.3% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $20.00K | $0.00 |
| YoY Change | ||
| Total Long-Term Assets | $280.9K | $810.7K |
| YoY Change | -65.35% | 617.34% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $45.43M | $48.79M |
| Total Long-Term Assets | $280.9K | $810.7K |
| Total Assets | $45.72M | $49.60M |
| YoY Change | -7.83% | -28.67% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $622.7K | $511.2K |
| YoY Change | 21.81% | -52.38% |
| Accrued Expenses | $2.483M | $3.100M |
| YoY Change | -19.92% | 63.16% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $3.105M | $3.596M |
| YoY Change | -13.64% | -83.38% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $9.960K | $300.0K |
| YoY Change | -96.68% | |
| Total Long-Term Liabilities | $9.960K | $300.0K |
| YoY Change | -96.68% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $3.105M | $3.596M |
| Total Long-Term Liabilities | $9.960K | $300.0K |
| Total Liabilities | $3.115M | $3.884M |
| YoY Change | -19.78% | -82.02% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$136.9M | -$133.1M |
| YoY Change | 2.81% | 9.15% |
| Common Stock | $179.5M | $178.9M |
| YoY Change | 0.35% | 5.28% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$17.63M | $45.72M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $45.72M | $49.60M |
| YoY Change | -7.83% | -28.67% |
Cashflow Statement
| Concept | 2020 Q2 | 2019 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$5.282M | -$5.684M |
| YoY Change | -7.07% | -5.11% |
| Depreciation, Depletion And Amortization | $30.17K | $20.00K |
| YoY Change | 50.85% | 100.0% |
| Cash From Operating Activities | $6.352M | -$5.140M |
| YoY Change | -223.58% | -139.21% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$12.20K | $120.0K |
| YoY Change | -110.17% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$12.20K | -$120.0K |
| YoY Change | -89.83% | |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 0.000 | |
| YoY Change | -100.0% | |
| NET CHANGE | ||
| Cash From Operating Activities | 6.352M | -5.140M |
| Cash From Investing Activities | -12.20K | -120.0K |
| Cash From Financing Activities | 0.000 | |
| Net Change In Cash | 6.340M | -5.260M |
| YoY Change | -220.53% | -109.56% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $6.352M | -$5.140M |
| Capital Expenditures | -$12.20K | $120.0K |
| Free Cash Flow | $6.364M | -$5.260M |
| YoY Change | -220.99% | -140.12% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q2 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
arpo:LicenseRevenueMember | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4481406 | ||
| CY2019Q2 | us-gaap |
Restructuring Costs
RestructuringCosts
|
915094 | |
| us-gaap |
Restructuring Costs
RestructuringCosts
|
915094 | ||
| arpo |
Grant Income
GrantIncome
|
79900 | ||
| arpo |
Grant Income
GrantIncome
|
20272 | ||
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
58666575 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
621685 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
50795435 | |
| CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
604661 | |
| us-gaap |
Profit Loss
ProfitLoss
|
5357369 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-14176441 | ||
| us-gaap |
Depreciation
Depreciation
|
30169 | ||
| us-gaap |
Depreciation
Depreciation
|
33503 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
635808 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1226346 | ||
| arpo |
Consulting Expenses Related To Warrants
ConsultingExpensesRelatedToWarrants
|
71939 | ||
| arpo |
Increase Decrease In Prepaid Research And Development Contracts
IncreaseDecreaseInPrepaidResearchAndDevelopmentContracts
|
-3754 | ||
| arpo |
Increase Decrease In Prepaid Research And Development Contracts
IncreaseDecreaseInPrepaidResearchAndDevelopmentContracts
|
-386344 | ||
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-491704 | ||
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-351376 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-238797 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-2045456 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
6351946 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-14224328 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
12198 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
232672 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12198 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-232672 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
6339748 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-14457000 | ||
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
38524536 | |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
33006494 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3918663 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | ||
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8492825 | |
| CY2020Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
9955 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
67438 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-142235522 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15000000 | ||
| us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
arpo:LicenseRevenueMember | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | ||
| CY2019Q2 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | |
| us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | ||
| us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | ||
| CY2019Q2 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | ||
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | ||
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4059 | |
| CY2020Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
178766806 | |
| CY2020Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-136878153 | |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
42600459 | |
| CY2020Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
45715695 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
36535343 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
39936786 | |
| CY2020Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
3401443 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
| CY2020Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
40588004 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
40588004 | |
| CY2020Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
40588004 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
40588004 | |
| CY2020Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15000000 | |
| CY2020Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
179474553 | |
| CY2020Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
4059 | |
| CY2020Q2 | us-gaap |
Liabilities
Liabilities
|
3115236 | |
| CY2019Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2799570 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5377614 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7850506 | ||
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1014874 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
678430 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.60 | |
| us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
623499 | ||
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
216389 | ||
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
643771 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
5357369 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-14176441 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.13 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40588004 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40588004 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40747960 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40588004 | ||
| CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
45716480 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6054612 | ||
| us-gaap |
Operating Expenses
OperatingExpenses
|
9859020 | ||
| us-gaap |
Operating Expenses
OperatingExpenses
|
14820212 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5140980 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14820212 | ||
| us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
136489 | ||
| CY2019Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2264255 | |
| CY2019Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
5978919 | |
| CY2019Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5978919 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
62347 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
327467 | |
| CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
9592 | |
| CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
308341 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
62614010 | |
| CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
44864284 | |
| CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
48157010 | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results may differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including: expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: prepaid and accrued research and development expense, stock-based compensation expense, revenue recognition and income taxes. </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s results can also be affected by economic conditions, global health concerns, such as COVID-19, and political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies, and changes in the prices of research studies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.</p> | ||
| us-gaap |
Intangible Assets Finite Lived Policy Costs Incurred To Renew Or Extend
IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend
|
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patents </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs incurred in connection with the application for and issuances of patents are expensed as incurred. </p> | ||
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
317562 | |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and Off-Balance Sheet Risk </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are the only financial instruments that potentially subject the Company to concentrations of credit risk. At June 30, 2020 and December 31, 2019, the Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements. </p> | ||
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.486 | |
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
5.00 | |
| CY2019 | arpo |
Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
|
P3Y | |
| CY2019Q4 | arpo |
Warrants Vesting Period
WarrantsVestingPeriod
|
P6M | |
| arpo |
Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
|
2024-10-24 | ||
| CY2019 | arpo |
Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
|
2020-03-15 | |
| CY2020Q2 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
15000000 | |
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | ||
| CY2020Q1 | arpo |
Number Of Class Of Warrants Expired
NumberOfClassOfWarrantsExpired
|
317562 | |
| CY2020Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2020Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2020Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2020Q2 | us-gaap |
Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
|
0 | |
| CY2019Q4 | us-gaap |
Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
|
0 | |
| CY2020Q2 | arpo |
Accrued Retention Bonus Current
AccruedRetentionBonusCurrent
|
918944 | |
| CY2019Q4 | arpo |
Accrued Retention Bonus Current
AccruedRetentionBonusCurrent
|
521859 | |
| CY2020Q2 | arpo |
Accrued Project Costs Current
AccruedProjectCostsCurrent
|
389854 | |
| CY2019Q4 | arpo |
Accrued Project Costs Current
AccruedProjectCostsCurrent
|
382131 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
346999 | |
| CY2020Q2 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
318591 | |
| CY2019Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
689830 | |
| CY2020Q2 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
278846 | |
| CY2019Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
793913 | |
| CY2020Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
79820 | |
| CY2019Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
43470 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
13463 | |
| us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
0 | ||
| CY2020Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
600000 | |
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
917562 | |
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
600000 | |
| CY2020Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5335850 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
962720 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
1452470 | ||
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2295314 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2550786 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.71 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.01 | ||
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.80 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
1.56 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.02 | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y2M23D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y4M20D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y11M23D | ||
| us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P5Y11M19D | ||
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
2866 | |
| CY2020Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
336444 | |
| CY2020Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
2108948 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.76 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.43 | ||
| CY2019Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y9M25D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y11M1D | ||
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0038 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0232 | ||
| CY2019Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.6597 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.6936 | ||
| CY2020Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y29D | |
| CY2020Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1328 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
59490 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
69685 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
129175 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.6583 | ||
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
8167 | |
| CY2020Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
121008 | |
| CY2020Q2 | us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
15000000 | |
| arpo |
Maximum Amount Of Milestone Payments Eligible To Receive Under License Agreement
MaximumAmountOfMilestonePaymentsEligibleToReceiveUnderLicenseAgreement
|
40000000 | ||
| arpo |
Maximum Amount Of Sales Milestone Payments Eligible To Receive Under License Agreement
MaximumAmountOfSalesMilestonePaymentsEligibleToReceiveUnderLicenseAgreement
|
50000000 | ||
| arpo |
Percentage Of Payments Received By Licensee
PercentageOfPaymentsReceivedByLicensee
|
0.20 | ||
| CY2019Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | ||
| CY2020Q2 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | |
| CY2020Q2 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | |
| CY2019Q4 | arpo |
Penalties On Termination Of Lease
PenaltiesOnTerminationOfLease
|
0 | |
| CY2020Q2 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
| CY2020Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
28357 | |
| CY2019Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
62085 | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
56715 | ||
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
124140 | ||
| CY2020Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
29145 | |
| CY2019Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
62154 | |
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
58290 | ||
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
124308 |
